The story of Viagra presents a challenging picture for shareholders. While the initial release generated massive profits, the expiration of its exclusive rights opened the avenue to off-brand alternatives, dramatically https://sahilxazb551201.blogoscience.com/48547427/the-copyright-and-big-pharma-a-volatile-opportunity